Obesity is a multifactorial disease with both genetic and environmental components. The
prevailing view is that obesity results from an imbalance between energy intake and …

Introduction: Second-generation antipsychotics (SGAs) are widely used in several
psychiatric disease entities and exert to a different extent a risk for antipsychotic-induced …

Antipsychotic medications are critical to child and adolescent psychiatry, from the
stabilization of psychotic disorders like schizophrenia, bipolar disorder, and psychotic …

Abstract Purpose of Review This narrative review synthesized recent research related to
obesity in adolescents with psychiatric disorders, with a focus on epidemiology …

Background Atypical antipsychotics, also known as second-generation antipsychotics, are
commonly prescribed as treatment for psychotic disorders in adults, as well as in children …

This meta-analysis examined the effectiveness and safety of metformin to prevent or treat
weight gain and metabolic abnormalities associated with antipsychotic drugs. We …

Objective To systematically examine the randomized controlled trial (RCT) evidence
regarding efficacy and tolerability of topiramate cotreatment with antipsychotics in …

Objective To present up-to-date information and recommendations on the management of
body weight changes during the use of antiepileptic mood stabilizers in bipolar disorder to …

To analyze weight gain, metabolic hormones, and homocysteine (Hcys) levels in children
and adolescents on antipsychotics (AP) during a year-long follow-up. 117 patients, AP-naïve …

Second-generation antipsychotics (SGAs) are commonly used to treat schizophrenia.
However, SGAs cause metabolic disturbances that can manifest as metabolic syndrome …